Inhibition of insulin secretion by aryl-substituted secondary aminoethanols.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D000242:Cyclic AMP / Q000494:pharmacology; D003864:Depression, Chemical; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D051379:Mice; D011433:Propranolol / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology*; D013424:Sulfanilamides / Q000494:pharmacology*; D013565:Sympatholytics; D014044:Tolbutamide / Q000494:pharmacology
D000605:Amino Alcohols; D001786:Blood Glucose; D007328:Insulin; D011437:Propylamines; D013424:Sulfanilamides; D013565:Sympatholytics; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D014044:Tolbutamide; D011433:Propranolol; D000242:Cyclic AMP; D005947:Glucose